Stephen Gottschalk

21.3k citations

256 papers · 12.2k indexed · 3 hit papers · h-index 64

Impact in

Oncology top 0.1%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
Immunology top 0.2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses

Papers in

Oncology 208
- CAR-T cell therapy research 159
- Viral-associated cancers and disorders 37
Immunology 101
- Immune Cell Function and Interaction 59
- Immunotherapy and Immune Responses 40

Co-authors: Cliona M. Rooney Helen E. Heslop Malcolm K. Brenner Gianpietro Dotti Sunitha Kakarla Nabil AhmedHao LiuBarbara Savoldo
Journals: Blood (40 papers)Biology of Blood and Marrow Transplantation (25 papers)Molecular Therapy (23 papers)Cytotherapy (12 papers)Journal of Immunotherapy (7 papers)
Partner nations: United States Germany France

In The Last Decade

Stephen Gottschalk

245 papers receiving 12.0k citations

Hit Papers

align trajectories log scale

VDAC2 loss elicits tumour destruction and inflammation for cancer therapy 2025 · 17 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 Nature
2013 Journal of Clinical Oncology
2013 Immunological Reviews

Peers

Countries citing papers authored by Stephen Gottschalk

Since Specialization

Citations

This map shows the geographic impact of Stephen Gottschalk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Gottschalk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Gottschalk more than expected).

Fields of papers citing papers by Stephen Gottschalk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Gottschalk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Gottschalk. The network helps show where Stephen Gottschalk may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stephen Gottschalk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen Gottschalk Line = papers co-authored together Stephen Gottschalk links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	VDAC2 loss elicits tumour destruction and inflammation for cancer therapy Nature ·Sujing Yuan, Renqiang Sun, Hao Shi, Nicole M. Chapman, Haoran Hu, Cliff Guy, Sherri L. Rankin, Anil KC, Chaudhari Pg, Xiaoxi Meng, 董科研 Dong Keyan, Peipei Zhou, Anderson Alvarenga Pereira, Stephen Gottschalk, Hongbo Chi Hit paper breakdown →	2025	17
2	Redirecting B7-H3.CAR T Cells to Chemokines Expressed in Osteosarcoma Enhances Homing and Antitumor Activity in Preclinical Models Clinical Cancer Research ·Lindsay J. Talbot, 正石井, Franck Morell, Alexandra Beckett, Phuong Nguyen, Andrew M. Fleming, Peter Chockley, Heather Sheppard, Jian Wang, Stephen Gottschalk, Christopher DeRenzo	2024	11
3	Motixafortide for Hematopoietic Stem and Progenitor Cell Mobilization and Collection in Sickle Cell Disease Blood ·Alexis Leonard, Akshay Sharma, Yogindra Persaud, В.Г. Маслов, Danielle L Pickett, R U Massey, Mümtaz Erakın, Eleonora Aquilini, Salem Akel, Jinghai Xie, Yan Zheng, Ella Sorani, Ching-Sung Lee, Mitchell J. Weiss, Stephen Gottschalk, Julie Kanter, Matthew M. Hsieh, John F. Tisdale	2024	2
4	Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication Nature Communications ·Michael D. Keller, Stefan Schattgen, Shanmuganathan Chandrakasan, E. Kaitlynn Allen, Y. Fujii, Christopher A. Lazarski, Muna Qayed, Haili Lang, Patrick J. Hanley, 清水岳美, Sung‐Yun Pai, Suhag Parikh, Seth Berger, Stephen Gottschalk, Michael A. Pulsipher, Paul G. Thomas, Catherine M. Bollard	2024	3
5	CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALL Blood Advances ·Rebecca Epperly, Barry L. Shulkin, Asim K. Bag, Cheng Cheng, Hiroto Inaba, John T. Lucas, Swati Naik, Brandon M. Triplett, Stephen Gottschalk, Aimee C. Talleur	2023	3
6	CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity Cancer Research Communications ·Dalia Haydar, Jorge Ibañez-Vega, Jeremy Chase Crawford, Ching‐Heng Chou, Clifford S. Guy, Liting Tian, Zhongzhen Yi, Scott Perry, Tomas Mankus, かおり阿部, Deanna Langfitt, Peter Vogel, Christopher DeRenzo, Stephen Gottschalk, Martine F. Roussel, Paul G. Thomas, Giedre Krenciute	2023	10
7	A Costimulatory CAR Improves TCR-based Cancer Immunotherapy Cancer Immunology Research ·Bilal Omer, Henry Murillier, Thomas Pfeiffer, 隆美小前, Jéssica Carvalho Dantas, Sandhya Sharma, Nazila Nouraee, Zhou Zi, Rosalía Anaya P., G Vourc'h, Kari Sandouka, 勝之山崎, Emily Salines, Thomas Shum, Stephen Gottschalk, Caroline Arber, Cliona M. Rooney	2022	19
8	Venetoclax-Based Combination Therapy As a Bridge to Allogeneic Hematopoietic Stem Cell Transplant in Children with Relapsed/Refractory AML Transplantation and Cellular Therapy ·Thomas Pfeiffer, Ying Li, Seth E. Karol, Jeffrey E. Rubnitz, Rebecca Epperly, Renee Madden, Ewelina Mamcarz, Esther A. Obeng, P. Stradina, Akshay Sharma, Ashok Srinivasan, Ali Suliman, Aimee C. Talleur, Mireya Paulina Velasquez, Stephen Gottschalk, Brandon M. Triplett, Swati Naik	2022	2
9	Engineering naturally occurring CD7− T cells for the immunotherapy of hematological malignancies Blood ·О.Б. Пичков, Jaquelyn T. Zoine, Jeremy Chase Crawford, Abishek Vaidya, Stefan Schattgen, Jacquelyn Myers, Sagar L. Patil, Mahsa Khanlari, Hiroto Inaba, Jeffery M. Klco, Charles G. Mullighan, Giedre Krenciute, Peter Chockley, Swati Naik, Deanna Langfitt, Maksim Mamonkin, Esther A. Obeng, Paul G. Thomas, Stephen Gottschalk, Mireya Paulina Velasquez	2022	43
10	A Chimeric GM-CSF/IL18 Receptor to Sustain CAR T-cell Function Cancer Discovery ·Sisi Nurwahyuni, 張智超, Matthew Bell, Sagar L. Patil, Deanna Langfitt, Stephen Gottschalk	2021	47
11	CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity Blood ·Tim Sauer, Kathan Parikh, Sandhya Sharma, Bilal Omer, クルニヤワンサェフラー, Qian Chen, Linus Angenendt, Christoph Schliemann, Michael Schmitt, Carsten Müller‐Tidow, Stephen Gottschalk, Cliona M. Rooney	2021	142
12	Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS Bone Marrow Transplantation ·Akshay Sharma, Ying Li, Sujuan Huang, Aimee C. Talleur, Ali Suliman, P. Stradina, Ashok Srinivasan, Ewelina Mamcarz, Renee Madden, Cheng Cheng, Stephen Gottschalk, Brandon M. Triplett	2021	8
13	Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer Journal for ImmunoTherapy of Cancer ·Saisha Nalawade, Paul Shafer, Pradip Bajgain, Mary K. McKenna, Miljana Stojčić, O.O. Bilokon, Jarrett Joubert, Stephen Gottschalk, Norihiro Watanabe, Ann M. Leen, Robin Parihar, Thalia Petronelli, Valentina Hoyos	2021	56
14	NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors Cancer Immunology Research ·Robin Parihar, Charlotte Helena Rivas, Jéssica Carvalho Dantas, Bilal Omer, Natalia Lapteva, Leonid S. Metelitsa, Stephen Gottschalk, Cliona M. Rooney	2019	219
15	Armed Oncolytic Adenovirus–Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors Cancer Research ·Kiyonori Tanoue, Amanda Rosewell Shaw, Norihiro Watanabe, Caroline Porter, Marc Laperrouza, Stephen Gottschalk, Malcolm K. Brenner, Masataka Suzuki	2017	180
16	CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T Cells Cancer Immunology Research ·Mireya Paulina Velasquez, Árpád Szöőr, Abishek Vaidya, Yumi Sato, Phuong Nguyen, Meng‐Fen Wu, Hao Liu, Stephen Gottschalk	2017	28
17	Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants Cancer Immunology Research ·Giedre Krenciute, Brooke Prinzing, Zhongzhen Yi, Meng-Fen Wu, Hao Liu, Gianpietro Dotti, Irina V. Balyasnikova, Stephen Gottschalk	2017	255
18	Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells Cancer Discovery ·Thomas Shum, Bilal Omer, Haruko Tashiro, Robert L. Kruse, Dimitrios L. Wagner, Kathan Parikh, Zhongzhen Yi, Tim Sauer, Daofeng Liu, Robin Parihar, Paul Castillo, Hao Liu, Malcolm K. Brenner, Leonid S. Metelitsa, Stephen Gottschalk, Cliona M. Rooney	2017	220
19	Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models Cancer Discovery ·Melinda Mata, Claudia Gerken, Phuong Nguyen, Giedre Krenciute, David M. Spencer, Stephen Gottschalk	2017	144
20	HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors Clinical Cancer Research ·Nabil Ahmed, Vita S. Salsman, Yvonne Kew, Donald R. Shaffer, Suzanne Z. Powell, Yi J Zhang, Robert G. Grossman, Helen E. Heslop, Stephen Gottschalk	2010	319

About Stephen Gottschalk

Stephen Gottschalk is a scholar working on Oncology, Immunology, Hematology, Genetics and Pathology and Forensic Medicine, having authored 256 papers that have together received 12.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (159 papers), Immune Cell Function and Interaction (59 papers), Virus-based gene therapy research (54 papers), Immunotherapy and Immune Responses (40 papers), Viral-associated cancers and disorders (37 papers), Cytomegalovirus and herpesvirus research (31 papers), Nanowire Synthesis and Applications (28 papers) and Hematopoietic Stem Cell Transplantation (26 papers). The work is most often cited by research in Oncology (9.4k citations), Immunology (4.7k citations), Genetics (3.1k citations), Hematology (728 citations) and Pathology and Forensic Medicine (1.1k citations). Stephen Gottschalk has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner, Gianpietro Dotti, Sunitha Kakarla, Nabil Ahmed, Hao Liu, Barbara Savoldo, Giedre Krenciute and Christopher DeRenzo. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Molecular Therapy, Cytotherapy and Journal of Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact